ArticleJournal of medical imaging and radiation oncology2025
Use and Perceptions of Oncology CT Structured Reports in Australia and New Zealand.
Article in Journal of medical imaging and radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionStructured oncology template (OT) reports are preferred by physicians. Promoted in Australia and New Zealand (ANZ) since 2008, this study investigates the current OT use in ANZ and perceptions around OT reporting.
methodsAn online survey was created and sent to > 350 ANZ radiologists, aiming to gain insight into the current rates of OT reporting, demographic variations, OT types, implementation and perceived advantages and limitations. Statistical analyses were descriptive.
resultsOf 164 respondents, 21% never used an OT; 49% used OTs for > 75% of oncology reports, highest rates were those with 10-20 years of experience (29/61) and reporting > 10 oncology CTs per week (10-20 cases 74% and > 20 cases 72%); 72% used tumour, lymph node and metastases headings; 57% used OTs for all diagnosed cancers; 37% used measurement tables; 70% used subjective terms in their conclusion; and only 4% used synoptic reports. Most selected advantage was 'More clarity and increased communication with clinicians'. Most selected disadvantage was 'lack of experience in template reporting' for those using an OT and 'Inflexible and limits creativity' for those who did not.
conclusionOT use is supported across ANZ. Use is higher in those reporting more oncology cases and with 10-20 years of experience. OT reports are perceived as beneficial by those using them, while those who do not perceive them as inflexible.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.